1-Methyl-2-(2-Hydroxyethyl)-7-(3-methylbutoxy)-9-(3-methylbutyl)-beta-carbolin-2-ium bromide

ID: ALA2164699

PubChem CID: 54767367

Max Phase: Preclinical

Molecular Formula: C24H35BrN2O2

Molecular Weight: 383.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c2c(cc[n+]1CCO)c1ccc(OCCC(C)C)cc1n2CCC(C)C.[Br-]

Standard InChI:  InChI=1S/C24H35N2O2.BrH/c1-17(2)8-12-26-23-16-20(28-15-10-18(3)4)6-7-21(23)22-9-11-25(13-14-27)19(5)24(22)26;/h6-7,9,11,16-18,27H,8,10,12-15H2,1-5H3;1H/q+1;/p-1

Standard InChI Key:  WQWPESUTDGGMLK-UHFFFAOYSA-M

Molfile:  

     RDKit          2D

 29 30  0  0  0  0  0  0  0  0999 V2000
    9.5195   -6.7761    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    5.1068   -7.9249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1056   -8.7522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8205   -9.1651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8187   -7.5121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5340   -7.9212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5343   -8.7476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3213   -9.0018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3199   -7.6656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8041   -8.3321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6214   -8.2452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9555   -7.4926    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4663   -6.8258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6508   -6.9160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3909   -9.1641    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1071   -8.9121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6767   -8.7511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7802   -7.4709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7136   -9.7276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2813  -10.4302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2114   -8.1742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6774   -7.9261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9633   -7.5130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9639   -6.6880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2484   -7.9250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4566  -10.4071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0242  -11.1097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0643   -9.6814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0360   -8.1525    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  7  2  0
  6  5  2  0
  5  2  1  0
  6  7  1  0
  7  8  1  0
  8 10  1  0
  9  6  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  3 15  1  0
 11 16  1  0
 15 17  1  0
 12 18  1  0
  8 19  1  0
 19 20  1  0
 18 21  1  0
 17 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 20 26  1  0
 26 27  1  0
 26 28  1  0
 21 29  1  0
M  CHG  2   1  -1  12   1
M  END

Associated Targets(Human)

OE33 (225 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hs 683 (377 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T98G (1524 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.56Molecular Weight (Monoisotopic): 383.2693AlogP: 4.85#Rotatable Bonds: 9
Polar Surface Area: 38.27Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 0.19CX LogD: 0.19
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.54Np Likeness Score: 0.11

References

1. Frédérick R, Bruyère C, Vancraeynest C, Reniers J, Meinguet C, Pochet L, Backlund A, Masereel B, Kiss R, Wouters J..  (2012)  Novel trisubstituted harmine derivatives with original in vitro anticancer activity.,  55  (14): [PMID:22770529] [10.1021/jm300542e]
2. Meinguet C, Bruyère C, Frédérick R, Mathieu V, Vancraeynest C, Pochet L, Laloy J, Mortier J, Wolber G, Kiss R, Masereel B, Wouters J..  (2015)  3D-QSAR, design, synthesis and characterization of trisubstituted harmine derivatives with in vitro antiproliferative properties.,  94  [PMID:25747498] [10.1016/j.ejmech.2015.02.044]

Source